Webinar: Beyond Urine and Saliva – Introducing Fingerprint Drug Testing

Webinar- Introducing Fingerprint Drug Testing

Share This Post

Webinar: Thursday November 20th

Time: 4PM AEDT | 9AM GST | 2PM JST | 10:30AM IST

Discover a faster, non-invasive, and more efficient approach to workplace drug testing. See firsthand how fingerprint drug testing streamlines sample collection, reduces labor, and improves compliance.

Why Traditional Testing Falls Short

Explore the limitations and challenges of traditional workplace drug testing methods, including urine and saliva. See how fingerprint sweat-based drug testing offers a faster, non-invasive, and more efficient alternative.

In this webinar, we’ll explore:

  • Limits of Traditional Drug Tests: Understand the operational, logistical, and employee experience challenges with traditional urine and saliva testing.
  • Fingerprint Drug Testing in Action: Watch a live demonstration of sample collection, analysis, and reporting.
  • Real-World Benefits: Learn the operational benefits of fingerprint drug testing.
  • Why It Works: Gain practical insights into why fingerprint testing is a compelling option for organizations looking to modernize their drug testing approach.

Speakers

Doug Heath, Vice President of Global Sales, Intelligent Bio Solutions

Peter Passaris, Vice President of Product Development, Intelligent Bio Solutions

Jayson Langley, Content Specialist, Intelligent Fingerprinting

Reserve Your Spot

INBS Reports Record Fiscal Q1 2027 Revenue of $1.39M

Intelligent Bio Solutions Reports Record Fiscal First Quarter 2027 Revenue of $1.39 Million, Marking Sixth Consecutive Quarter of Year-Over-Year Growth

NEW YORK, November 10, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results and operational highlights for the fiscal first quarter ended September 30, 2026. “Fiscal first quarter revenue was the highest quarterly revenue in our Company’s…

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance

NEW YORK, September 09, 2026 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the submission of its 510(k) premarket notification to the U.S. Food and Drug Administration (FDA),  seeking regulatory clearance of its Intelligent Fingerprinting Drug Screening System (the “System”)…

Sign Up

Subscribe to receive the latest news and updates from Intelligent Bio Solutions.

Request a Fingerprint Drug Test Demonstration

Non-invasive, cost-effective, and efficient workplace drug testing

Learn how our Intelligent Fingerprinting Drug Test can work for your business.

Book a no-obligation online or in-person demonstration today.